Germany’s Expert Committee for Prescription has at its most recent meeting rejected the Rx-to-OTC switch of the progestogen-only contraceptive pill (desogestrel 75μg).
The short minutes of the meeting which took place on 23 January show that the switch application, put forward by Perrigo, was unanimously rejected by
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?